Graduate Program in Cellular and Molecular Physiology, Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, MA, USA.
Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, MA, USA.
Biochim Biophys Acta Mol Cell Res. 2019 Dec;1866(12):118552. doi: 10.1016/j.bbamcr.2019.118552. Epub 2019 Sep 2.
KIF13B, a kinesin-3 family motor, was originally identified as GAKIN due to its biochemical interaction with human homolog of Drosophila discs-large tumor suppressor (hDLG1). Unlike its homolog KIF13A, KIF13B contains a carboxyl-terminal CAP-Gly domain. To investigate the function of the CAP-Gly domain, we developed a mouse model that expresses a truncated form of KIF13B protein lacking its CAP-Gly domain (KIF13BΔCG), whereas a second mouse model lacks the full-length KIF13A. Here we show that the KIF13BΔCG mice exhibit relatively higher serum cholesterol consistent with the reduced uptake of [H]CO-LDL in KIF13BΔCG mouse embryo fibroblasts. The plasma level of factor VIII was not significantly elevated in the KIF13BΔCG mice, suggesting that the CAP-Gly domain region of KIF13B selectively regulates LRP1-mediated lipoprotein endocytosis. No elevation of either serum cholesterol or plasma factor VIII was observed in the full length KIF13A null mouse model. The deletion of the CAP-Gly domain region caused subcellular mislocalization of truncated KIF13B concomitant with the mislocalization of LRP1. Mechanistically, the cytoplasmic domain of LRP1 interacts specifically with the alternatively spliced I domain of DLG1, which complexes with KIF13B via their GUK-MBS domains, respectively. Importantly, double mutant mice generated by crossing KIF13A null and KIF13BΔCG mice suffer from perinatal lethality showing potential craniofacial defects. Together, this study provides first evidence that the carboxyl-terminal region of KIF13B containing the CAP-Gly domain is important for the LRP1-DLG1-KIF13B complex formation with implications in the regulation of metabolism, cell polarity, and development.
KIF13B 是一种驱动蛋白-3 家族的马达蛋白,最初因其与果蝇盘状结构域大肿瘤抑制因子(hDLG1)的人类同源物的生化相互作用而被鉴定为 GAKIN。与它的同源物 KIF13A 不同,KIF13B 含有羧基末端的 CAP-Gly 结构域。为了研究 CAP-Gly 结构域的功能,我们构建了一个表达缺乏 CAP-Gly 结构域的 KIF13B 蛋白截断形式(KIF13BΔCG)的小鼠模型,而另一个小鼠模型缺乏全长 KIF13A。在这里,我们表明 KIF13BΔCG 小鼠表现出相对较高的血清胆固醇,这与 KIF13BΔCG 小鼠胚胎成纤维细胞中 [H]CO-LDL 的摄取减少一致。KIF13BΔCG 小鼠的因子 VIII 血浆水平没有显著升高,表明 KIF13B 的 CAP-Gly 结构域区域选择性调节 LRP1 介导的脂蛋白内吞作用。在全长 KIF13A 缺失小鼠模型中,未观察到血清胆固醇或血浆因子 VIII 的升高。CAP-Gly 结构域区域的缺失导致截断的 KIF13B 的亚细胞定位错误,同时 LRP1 的定位错误。在机制上,LRP1 的细胞质结构域与 DLG1 的可选择剪接的 I 结构域特异性相互作用,该 I 结构域分别与 KIF13B 通过其 GUK-MBS 结构域复合物。重要的是,通过将 KIF13A 缺失和 KIF13BΔCG 小鼠杂交产生的双突变小鼠在围产期死亡,表现出潜在的颅面缺陷。总之,这项研究提供了第一个证据,表明 KIF13B 的羧基末端含有 CAP-Gly 结构域的区域对于 LRP1-DLG1-KIF13B 复合物的形成很重要,这对代谢、细胞极性和发育的调节具有重要意义。